Deep Track Capital, LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Nektar Therapeutics (NKTR)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Nektar Therapeutics Common Stock, par value $0.0001
Symbol
NKTR
Shares outstanding
185M shares
Disclosed Ownership
1.98M shares
Ownership
1.07%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 08:43 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 1.07% 1.98M 0 1.98M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 1.07% 1.98M 0 1.98M /s/ David Kroin David Kroin, Director
David Kroin 1.07% 1.98M 0 1.98M /s/ David Kroin David Kroin